vs

Side-by-side financial comparison of OppFi Inc. (OPFI) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

OppFi Inc. is the larger business by last-quarter revenue ($85.6M vs $83.1M, roughly 1.0× PROCEPT BioRobotics Corp). OppFi Inc. runs the higher net margin — 19.7% vs -38.1%, a 57.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 5.9%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 16.3%).

OppFi Inc. is a US-headquartered financial technology firm that provides responsible, accessible financial solutions including installment loans, credit-building tools and related support services to consumers underserved by traditional banking institutions, prioritizing fair terms to help users boost their long-term financial wellness.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

OPFI vs PRCT — Head-to-Head

Bigger by revenue
OPFI
OPFI
1.0× larger
OPFI
$85.6M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+14.3% gap
PRCT
20.2%
5.9%
OPFI
Higher net margin
OPFI
OPFI
57.7% more per $
OPFI
19.7%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
16.3%
OPFI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OPFI
OPFI
PRCT
PRCT
Revenue
$85.6M
$83.1M
Net Profit
$16.8M
$-31.6M
Gross Margin
64.9%
Operating Margin
36.1%
-4.1%
Net Margin
19.7%
-38.1%
Revenue YoY
5.9%
20.2%
Net Profit YoY
400.3%
-27.9%
EPS (diluted)
$1.48
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPFI
OPFI
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$85.6M
$76.4M
Q3 25
$104.6M
$83.3M
Q2 25
$100.2M
$79.2M
Q1 25
$90.8M
$69.2M
Q4 24
$80.8M
$68.2M
Q3 24
$91.2M
$58.4M
Q2 24
$86.3M
$53.4M
Net Profit
OPFI
OPFI
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$16.8M
$-29.8M
Q3 25
$41.6M
$-21.4M
Q2 25
$-20.8M
$-19.6M
Q1 25
$-11.4M
$-24.7M
Q4 24
$-5.6M
$-18.9M
Q3 24
$4.3M
$-21.0M
Q2 24
$3.1M
$-25.6M
Gross Margin
OPFI
OPFI
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
OPFI
OPFI
PRCT
PRCT
Q1 26
-4.1%
Q4 25
36.1%
-40.6%
Q3 25
46.3%
-27.8%
Q2 25
44.7%
-28.0%
Q1 25
46.8%
-39.7%
Q4 24
30.5%
-28.9%
Q3 24
38.5%
-38.4%
Q2 24
34.2%
-50.3%
Net Margin
OPFI
OPFI
PRCT
PRCT
Q1 26
-38.1%
Q4 25
19.7%
-39.1%
Q3 25
39.8%
-25.7%
Q2 25
-20.7%
-24.7%
Q1 25
-12.5%
-35.8%
Q4 24
-6.9%
-27.6%
Q3 24
4.7%
-35.9%
Q2 24
3.6%
-48.0%
EPS (diluted)
OPFI
OPFI
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$1.48
$-0.54
Q3 25
$0.77
$-0.38
Q2 25
$-0.78
$-0.35
Q1 25
$-0.48
$-0.45
Q4 24
$-0.11
$-0.34
Q3 24
$0.21
$-0.40
Q2 24
$0.16
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPFI
OPFI
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$49.5M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$58.5M
$347.7M
Total Assets
$754.1M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPFI
OPFI
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$49.5M
$286.5M
Q3 25
$45.5M
$294.3M
Q2 25
$45.2M
$302.7M
Q1 25
$58.0M
$316.2M
Q4 24
$61.3M
$333.7M
Q3 24
$44.8M
$196.8M
Q2 24
$46.6M
$214.1M
Total Debt
OPFI
OPFI
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
OPFI
OPFI
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$58.5M
$365.9M
Q3 25
$49.4M
$380.3M
Q2 25
$13.4M
$385.8M
Q1 25
$22.6M
$389.2M
Q4 24
$32.8M
$402.2M
Q3 24
$34.9M
$241.2M
Q2 24
$18.6M
$251.8M
Total Assets
OPFI
OPFI
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$754.1M
$508.1M
Q3 25
$720.6M
$511.5M
Q2 25
$673.4M
$513.1M
Q1 25
$640.1M
$519.4M
Q4 24
$641.2M
$534.0M
Q3 24
$619.3M
$374.1M
Q2 24
$573.1M
$374.4M
Debt / Equity
OPFI
OPFI
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPFI
OPFI
PRCT
PRCT
Operating Cash FlowLast quarter
$401.3M
Free Cash FlowOCF − Capex
$382.2M
FCF MarginFCF / Revenue
446.6%
Capex IntensityCapex / Revenue
22.3%
Cash ConversionOCF / Net Profit
23.82×
TTM Free Cash FlowTrailing 4 quarters
$652.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPFI
OPFI
PRCT
PRCT
Q1 26
Q4 25
$401.3M
$-10.3M
Q3 25
$105.1M
$-6.6M
Q2 25
$95.6M
$-15.0M
Q1 25
$83.7M
$-17.0M
Q4 24
$323.8M
$-32.4M
Q3 24
$77.6M
$-18.8M
Q2 24
$77.3M
$-15.7M
Free Cash Flow
OPFI
OPFI
PRCT
PRCT
Q1 26
Q4 25
$382.2M
$-12.2M
Q3 25
$99.9M
$-9.5M
Q2 25
$91.0M
$-17.8M
Q1 25
$79.3M
$-18.8M
Q4 24
$310.8M
$-33.6M
Q3 24
$73.7M
$-19.0M
Q2 24
$74.7M
$-16.8M
FCF Margin
OPFI
OPFI
PRCT
PRCT
Q1 26
Q4 25
446.6%
-15.9%
Q3 25
95.6%
-11.4%
Q2 25
90.8%
-22.5%
Q1 25
87.4%
-27.2%
Q4 24
384.6%
-49.2%
Q3 24
80.8%
-32.6%
Q2 24
86.6%
-31.4%
Capex Intensity
OPFI
OPFI
PRCT
PRCT
Q1 26
Q4 25
22.3%
2.4%
Q3 25
5.0%
3.4%
Q2 25
4.6%
3.5%
Q1 25
4.8%
2.7%
Q4 24
16.1%
1.7%
Q3 24
4.3%
0.4%
Q2 24
3.0%
2.0%
Cash Conversion
OPFI
OPFI
PRCT
PRCT
Q1 26
Q4 25
23.82×
Q3 25
2.52×
Q2 25
Q1 25
Q4 24
Q3 24
18.19×
Q2 24
25.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPFI
OPFI

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons